Azure Biosystems manufactures and sells imaging systems and reagents for life science researchers. The company is led by its founder, largest investor and third-time CEO who has a range of experiences. The team’s approach to the market is to identify heavily used products and workflows that feature old technology (usually instrument platforms). Then they enter the market with a much-improved product that quickly gains share before the incumbent has a chance to respond. This strategy has been successful and led them to over $10 million in revenues the last few years.
